Related Experiment Video
Updated: Apr 1, 2026

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
Fluoroquinolone-induced serious, persistent, multisymptom adverse effects
Beatrice Alexandra Golomb1, Hayley Jean Koslik1, Alan J Redd2
1Department of Medicine, University of California, San Diego, La Jolla, California, USA.
Abstract:
We present a case series of four previously healthy, employed adults without significant prior medical history in each of whom symptoms developed while on fluoroquinolones (FQs), with progression that continued following discontinuation evolving to a severe, disabling multisymptom profile variably involving tendinopathy, muscle weakness, peripheral neuropathy, autonomic dysfunction, sleep disorder, cognitive dysfunction and psychiatric disturbance. Physicians and patients should be alert to the potential for FQ-induced severe disabling multisymptom pathology that may persist and progress following FQ use. Known induction by FQs of delayed mitochondrial toxicity provides a compatible mechanism, with symptom profiles (and documented mechanisms of FQ toxicity) compatible with the hypothesis of an exposure-induced mitochondrial neurogastrointestinal encephalomyopathy.
Insights
Fluoroquinolones (FQs) can cause severe, disabling symptoms like tendinopathy and neuropathy that persist after use. This mitochondrial toxicity may lead to a severe multisymptom condition.
Area of Science:
- Pharmacology
- Neurology
- Toxicology
Background:
- Fluoroquinolones (FQs) are broad-spectrum antibiotics.
- Potential adverse effects of FQs are increasingly recognized.
Observation:
- Four previously healthy adults developed severe, multisystem symptoms during or after FQ use.
- Symptoms included tendinopathy, muscle weakness, neuropathy, autonomic dysfunction, sleep and cognitive disturbances, and psychiatric issues.
Findings:
- Symptoms persisted and progressed even after FQ discontinuation.
- The observed pathology aligns with FQ-induced delayed mitochondrial toxicity.
- This suggests a potential mechanism for fluoroquinolone-induced mitochondrial neurogastrointestinal encephalomyopathy.
Implications:
- Physicians and patients should be aware of the risk of severe, persistent FQ toxicity.
- Early recognition and discontinuation of FQs may be crucial.
- Further research into FQ-induced mitochondrial dysfunction is warranted.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
Mechanism of Antibiotic Resistance in MRSA
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

